Olanzapine augmentation in panic disorder: A case report

Pharmacopsychiatry

Volumn 37, Issue 5, 2004, Pages 239-240

  Chao, Iou Lin ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; FLUDIAZEPAM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADD ON THERAPY; ADULT; AGORAPHOBIA; ANXIETY; ANXIETY DISORDER; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; HUMAN; LIBIDO DISORDER; MALE; OUTCOMES RESEARCH; PANIC; PRIORITY JOURNAL; REMISSION; SEXUAL DYSFUNCTION; SYMPTOM; TRANQUILIZING ACTIVITY; TREATMENT FAILURE;

AGORAPHOBIA; BENZODIAZEPINES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PAROXETINE; SEROTONIN UPTAKE INHIBITORS;

EID: 4644305447     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832600     Document Type: Article

References (6)

1. Etxebeste M, Aragues E, Malo P, Pacheco L. Olanzapine and panic attacks. Am J Psychiatry 2000 Apr; 157(4): 659-60
2. Mathew SJ, Coplan JD, Gorman JM. Management of treatment-refractory panic disorder. Psychopharmacol Bull 2001 Spring; 35(2): 97-110
3. 2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology 1997; 16: 1-7
4. Roy-Byrne PP, Cowley DS. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety 1994-1995; 1(4): 151-60
5. Shelton RC, Tollefson GD, Tohen M, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001; 158: 31-134
6. Work Group on Panic Disorder, American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 1998 May; 155(5 Suppl): 1-34